NuGen Medical Devices Inc. Stock

Equities

NGMD

CA67054F1009

Medical Equipment, Supplies & Distribution

Market Closed - Toronto S.E. 03:59:59 2024-04-25 pm EDT 5-day change 1st Jan Change
0.11 CAD 0.00% Intraday chart for NuGen Medical Devices Inc. -4.35% -8.33%
Sales 2021 0.14 0.19 Sales 2022 0.15 0.21 Capitalization 3.86M 5.27M
Net income 2021 -7M -9.55M Net income 2022 -5M -6.82M EV / Sales 2021 121,766,361 x
Net Debt 2021 3.86M 5.26M Net Debt 2022 7.28M 9.92M EV / Sales 2022 73,104,051 x
P/E ratio 2021
-2.9 x
P/E ratio 2022
-0.65 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 92.09%
More Fundamentals * Assessed data
Dynamic Chart
NuGen Medical Devices Inc. Receives Two Additional Sales Orders for InsuJet and Expands Distribution into Argentina, Chile, Costa Rica and Peru CI
NuGen Medical Devices Inc. Signs 5-Year Distribution Agreement for InsuJet with Verrue Consulting Group in Belgium CI
NuGen Medical Signs 5-Year Distribution Agreement for InsuJet with Advance Medical Life CI
NuGen Medical Devices Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
NuGen Medical Devices Inc. Reports Distribution Agreement with Science-Link Trading SAPI de CV CI
Nugen Medical Devices Inc. Announces the Official Launch on Shopify of Its Diabetic's Lifestyle Subscription Business CI
NuGen Medical Devices Inc. Announces Chief Executive Officer Changes CI
NuGen Medical Devices Inc. Presents New Data from Preliminary Trial That Semaglutide (Ozempic ) Is Chemically Stable After It Is Administered Through Nugen 's InsuJet Needle-Free Injection Device CI
NuGen Medical Devices Inc. Completes Delivery and First Sale of 500 InsuJet Devices and Consumables in Romania CI
NuGen Medical Devices Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
NuGen Medical Devices Inc. Enters into Distribution Agreement with Sol-Millennium Medical Inc CI
NuGen Medical Devices Inc. Announces Executive Changes CI
Nugen Medical Devices Inc. Announces InsuJetTM Now Registered for Supply Through Reliance Medical Group CI
NuGen Medical Devices Inc. Receives its First Bulk Purchase Order from Science-Link Trading SAPI de CV for the Mexican Market for 500 Units of the Company's Needly-Free InsuJet InsuJet InsuJet™? Injection Device CI
NuGen Medical Devices Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
More news
1 week-4.35%
1 month-4.35%
3 months+15.79%
6 months+10.00%
Current year-8.33%
More quotes
1 week
0.11
Extreme 0.11
0.12
1 month
0.11
Extreme 0.11
0.14
Current year
0.09
Extreme 0.09
0.15
1 year
0.09
Extreme 0.09
0.26
3 years
0.04
Extreme 0.035
0.53
5 years
0.04
Extreme 0.035
0.53
10 years
0.04
Extreme 0.035
0.53
More quotes
Managers TitleAgeSince
Chief Executive Officer - Oct. 31
Chief Executive Officer 54 -
Director of Finance/CFO 41 21-09-30
Members of the board TitleAgeSince
Chief Executive Officer 54 -
Director/Board Member 51 21-10-18
Chairman 53 -
More insiders
Date Price Change Volume
24-04-25 0.11 0.00% 11,500
24-04-24 0.11 0.00% 141,228
24-04-23 0.11 0.00% 109,500
24-04-22 0.11 -4.35% 125,000
24-04-19 0.115 0.00% 22,000

Delayed Quote Toronto S.E., April 25, 2024 at 03:59 pm EDT

More quotes
NuGen Medical Devices Inc. is a Canada-based specialty medical device company. The Company is engaged in marketing and selling its InsuJet needle-free injection system designed to improve the lives of millions of diabetics. Its principal business is the research, development and commercialization of needle-free injection devices and systems for the administration of subcutaneous medication. It is developing products using its needle-free delivery technology in several fields including, but not limited to, diabetes, semaglutide, growth and fertility hormone, as well as deoxyribonucleic acid (DNA) and conventional/pediatric vaccines. It is focusing its development efforts on needle free devices in the area of liquid jet delivery through the InsuJet platform. The Company's InsuJet technology platform is based on jet-stream administration of liquid drugs. The Company manufactures and commercializes needle-free injection systems and sells in over 40 countries globally.
More about the company